ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

Christopher Coyle, Fay H. Cafferty, Samuel Rowley, Mairead Mackenzie, Lindy Berkman, Sudeep Gupta, C S Pramesh, Duncan Gilbert, Howard Kynaston, David Cameron, Richard H. Wilson, Alistair Ring, Ruth E. Langley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)56-64
JournalContemporary Clinical Trials
Publication statusPublished - 21 Oct 2016

Cite this